Splice Histology and SauveBio are thrilled to announce a collaborative partnership designed to streamline pre-clinical research for the biotech and pharmaceutical communities.
Splice Histology provides customers with expert driven histology, IHC, and IF assay development with their board-certified histologists at the helm of tissue workflow. With their science-first approach, they partner with their clients to ensure that your histological and assay development needs are met with the highest standards of rigor, reproducibility, and translational relevance.
Together, Splice and SauveBio create a seamless workflow, from tissue processing, to assay development, to single-cell and spatial analysis. By bridging morphological context with phenotypic depth, researchers can:
- Correlate tissue structure with cellular function by combining IHC/IF results with single cell-resolution flow cytometry data to gain deeper mechanistic insights
- Isolate novel cell populations first identified using histology for downstream studies
- Accelerate translational research with more robust pre-clinical data for drug discovery and biomarker development
With both organizations located in Worcester, communication and sample logistics are streamlined. This enables quicker turnaround times, greater consistency, and efficient scientific collaboration.
We invite you to contact Splice Histology or SauveBio to explore how this partnership can accelerate your pre-clinical workflows. Together, we can advance research with expertise and reliability, on a foundation of scientific collaboration, helping each other advance discovery with transparent communication.